2018
Our Ethical Obligation to Treat Opioid Use Disorder in Prisons: A Patient and Physician's Perspective
Bone C, Eysenbach L, Bell K, Barry DT. Our Ethical Obligation to Treat Opioid Use Disorder in Prisons: A Patient and Physician's Perspective. The Journal Of Law, Medicine & Ethics 2018, 46: 268-271. PMID: 30146992, DOI: 10.1177/1073110518782933.Peer-Reviewed Original ResearchConceptsOpioid use disorderUse disordersHepatitis C transmissionMedication-assisted treatmentHealth care providersPublic health threatLower ratesPoor outcomeOpioid epidemicImproved outcomesOpioid overdoseCare providersPhysician perspectivesLower riskC transmissionTreatment approachesDrug useHealth disparitiesInfectious diseasesHealth threatAccidental deathGold standardDisordersOverdoseIncarcerated individuals
2014
Primary Care–Based Buprenorphine Taper vs Maintenance Therapy for Prescription Opioid Dependence: A Randomized Clinical Trial
Fiellin DA, Schottenfeld RS, Cutter CJ, Moore BA, Barry DT, O’Connor P. Primary Care–Based Buprenorphine Taper vs Maintenance Therapy for Prescription Opioid Dependence: A Randomized Clinical Trial. JAMA Internal Medicine 2014, 174: 1947-1954. PMID: 25330017, PMCID: PMC6167926, DOI: 10.1001/jamainternmed.2014.5302.Peer-Reviewed Original ResearchConceptsPrescription opioid dependenceOngoing maintenance therapyIllicit opioid useMaintenance therapyOpioid dependenceBuprenorphine taperBuprenorphine therapyTaper groupMaintenance groupOpioid usePrimary careClinical trialsPrimary care-based treatmentSignificant public health burdenBuprenorphine maintenance therapyOngoing maintenance treatmentPrimary care physiciansEvidence-based guidelinesPrimary care sitesPublic health burdenWeeks of stabilizationHydrochloride therapyOpioid withdrawalBuprenorphine treatmentNaltrexone treatment